Non-alcoholic fatty liver disease, now MASLD, is alarmingly prevalent among young, sedentary Indians. Studies reveal high ...

The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

According to a 2018 article, at least 25 percent of adults have metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease.

Mar. 24, 2025 — A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both ...

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

Non-alcoholic fatty liver disease is rising rapidly in India, driven by poor diet and lifestyle. Early detection and ...

Nonalcoholic fatty liver disease (NAFLD) has limited dietary treatment options. Here, the authors show that torularhodin, a microbial carotenoid, alleviates NAFLD by enriching Akkermansia ...